Dr. Robert F Hosty, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 996 Howard Ct, Baldwin, NY 11510 Phone: 516-623-3695 |
News Archive
The U.S FDA have pushed back the deadline for deciding whether to approve an experimental anticlotting drug developed jointly by Pfizer Inc. and Bristol-Myers Squibb Co. The companies said late Wednesday that the Food and Drug Administration has set a new target date of June 28 for deciding whether to approve Eliquis. That's three months later than originally scheduled.
We often make quick strategic decisions to attack an opponent or defend our position, yet how we make them is not well understood. Now, researchers at the RIKEN Brain Science Institute in Japan have pinpointed specific brain regions related to this process by examining neural activity in people playing shogi, a Japanese form of chess.
An analysis of over 1000 individuals presenting with suspected exudative age-related macular degeneration has revealed which factors are most predictive of the need for treatment.
Syneron Medical Ltd., a leading global aesthetic device company, announced today that it will host an investor meeting on Wednesday, September 17, 2014, at approximately 10:00 am to 1:00 pm ET in New York City. The meeting will highlight Syneron's opportunity in the fast growing body contouring and fat treatment market, with a focus on the UltraShape system, which received FDA clearance for fat cell destruction in April 2014.
Scientists have built a model that predicts how temperature affects the spread of Ross River virus, a common mosquito-borne virus in Australia, according to a report in the journal eLife.
› Verified 6 days ago